Our laboratory does no direct patient billing, and I have a question regarding billing and reimbursement (primarily Medicare, but also insurance companies) It is my understanding that a clinical flow cytometry laboratory can bill for each antibody used, which in an extensive leukemia/lymphoma work-up can add up to significant cost. How are people billing for their cases and how are they being reimbursed? Do the insurance companies and Medicare have a limit on how many antibodies they are reimbursing for? Thanks in advance for your comments. Michael S. Brown, MD Department of Pathology University of Utah ARUP Laboratories, Inc.
This archive was generated by hypermail 2b29 : Sat Mar 10 2001 - 19:31:19 EST